img

Global Acalabrutinib Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Acalabrutinib Market Research Report 2024

Acalabrutinib (ACP-196) is an orally active, irreversible, and highly selective second-generation BTK inhibitor. Acalabrutinib binds covalently to Cys481 in the ATP-binding pocket of BTK. Acalabrutinib demonstrates potent on-target effects and efficacy in mouse models of chronic lymphocytic leukemia (CLL).
According to MRAResearch’s new survey, global Acalabrutinib market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Acalabrutinib market research.
Key companies engaged in the Acalabrutinib industry include AstraZeneca Pharmaceuticals LP, Cephalon, Inc, Genentech, Inc and Cayman Chemical Company, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Acalabrutinib were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Acalabrutinib market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Acalabrutinib market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AstraZeneca Pharmaceuticals LP
Cephalon, Inc
Genentech, Inc
Cayman Chemical Company
Segment by Type
Biopharmaceutical Grade
Laboratory Grade

Segment by Application


Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Acalabrutinib report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acalabrutinib Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Biopharmaceutical Grade
1.2.3 Laboratory Grade
1.3 Market by Application
1.3.1 Global Acalabrutinib Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acalabrutinib Market Perspective (2018-2033)
2.2 Acalabrutinib Growth Trends by Region
2.2.1 Global Acalabrutinib Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Acalabrutinib Historic Market Size by Region (2018-2023)
2.2.3 Acalabrutinib Forecasted Market Size by Region (2024-2033)
2.3 Acalabrutinib Market Dynamics
2.3.1 Acalabrutinib Industry Trends
2.3.2 Acalabrutinib Market Drivers
2.3.3 Acalabrutinib Market Challenges
2.3.4 Acalabrutinib Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acalabrutinib Players by Revenue
3.1.1 Global Top Acalabrutinib Players by Revenue (2018-2023)
3.1.2 Global Acalabrutinib Revenue Market Share by Players (2018-2023)
3.2 Global Acalabrutinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acalabrutinib Revenue
3.4 Global Acalabrutinib Market Concentration Ratio
3.4.1 Global Acalabrutinib Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acalabrutinib Revenue in 2022
3.5 Acalabrutinib Key Players Head office and Area Served
3.6 Key Players Acalabrutinib Product Solution and Service
3.7 Date of Enter into Acalabrutinib Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acalabrutinib Breakdown Data by Type
4.1 Global Acalabrutinib Historic Market Size by Type (2018-2023)
4.2 Global Acalabrutinib Forecasted Market Size by Type (2024-2033)
5 Acalabrutinib Breakdown Data by Application
5.1 Global Acalabrutinib Historic Market Size by Application (2018-2023)
5.2 Global Acalabrutinib Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Acalabrutinib Market Size (2018-2033)
6.2 North America Acalabrutinib Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Acalabrutinib Market Size by Country (2018-2023)
6.4 North America Acalabrutinib Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acalabrutinib Market Size (2018-2033)
7.2 Europe Acalabrutinib Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Acalabrutinib Market Size by Country (2018-2023)
7.4 Europe Acalabrutinib Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acalabrutinib Market Size (2018-2033)
8.2 Asia-Pacific Acalabrutinib Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Acalabrutinib Market Size by Region (2018-2023)
8.4 Asia-Pacific Acalabrutinib Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acalabrutinib Market Size (2018-2033)
9.2 Latin America Acalabrutinib Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Acalabrutinib Market Size by Country (2018-2023)
9.4 Latin America Acalabrutinib Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acalabrutinib Market Size (2018-2033)
10.2 Middle East & Africa Acalabrutinib Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Acalabrutinib Market Size by Country (2018-2023)
10.4 Middle East & Africa Acalabrutinib Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca Pharmaceuticals LP
11.1.1 AstraZeneca Pharmaceuticals LP Company Detail
11.1.2 AstraZeneca Pharmaceuticals LP Business Overview
11.1.3 AstraZeneca Pharmaceuticals LP Acalabrutinib Introduction
11.1.4 AstraZeneca Pharmaceuticals LP Revenue in Acalabrutinib Business (2018-2023)
11.1.5 AstraZeneca Pharmaceuticals LP Recent Development
11.2 Cephalon, Inc
11.2.1 Cephalon, Inc Company Detail
11.2.2 Cephalon, Inc Business Overview
11.2.3 Cephalon, Inc Acalabrutinib Introduction
11.2.4 Cephalon, Inc Revenue in Acalabrutinib Business (2018-2023)
11.2.5 Cephalon, Inc Recent Development
11.3 Genentech, Inc
11.3.1 Genentech, Inc Company Detail
11.3.2 Genentech, Inc Business Overview
11.3.3 Genentech, Inc Acalabrutinib Introduction
11.3.4 Genentech, Inc Revenue in Acalabrutinib Business (2018-2023)
11.3.5 Genentech, Inc Recent Development
11.4 Cayman Chemical Company
11.4.1 Cayman Chemical Company Company Detail
11.4.2 Cayman Chemical Company Business Overview
11.4.3 Cayman Chemical Company Acalabrutinib Introduction
11.4.4 Cayman Chemical Company Revenue in Acalabrutinib Business (2018-2023)
11.4.5 Cayman Chemical Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Acalabrutinib Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Biopharmaceutical Grade
Table 3. Key Players of Laboratory Grade
Table 4. Global Acalabrutinib Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Acalabrutinib Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Acalabrutinib Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Acalabrutinib Market Share by Region (2018-2023)
Table 8. Global Acalabrutinib Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Acalabrutinib Market Share by Region (2024-2033)
Table 10. Acalabrutinib Market Trends
Table 11. Acalabrutinib Market Drivers
Table 12. Acalabrutinib Market Challenges
Table 13. Acalabrutinib Market Restraints
Table 14. Global Acalabrutinib Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Acalabrutinib Market Share by Players (2018-2023)
Table 16. Global Top Acalabrutinib Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acalabrutinib as of 2022)
Table 17. Ranking of Global Top Acalabrutinib Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Acalabrutinib Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acalabrutinib Product Solution and Service
Table 21. Date of Enter into Acalabrutinib Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acalabrutinib Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Acalabrutinib Revenue Market Share by Type (2018-2023)
Table 25. Global Acalabrutinib Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Acalabrutinib Revenue Market Share by Type (2024-2033)
Table 27. Global Acalabrutinib Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Acalabrutinib Revenue Market Share by Application (2018-2023)
Table 29. Global Acalabrutinib Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Acalabrutinib Revenue Market Share by Application (2024-2033)
Table 31. North America Acalabrutinib Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Acalabrutinib Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Acalabrutinib Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Acalabrutinib Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Acalabrutinib Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Acalabrutinib Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Acalabrutinib Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Acalabrutinib Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Acalabrutinib Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Acalabrutinib Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Acalabrutinib Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Acalabrutinib Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Acalabrutinib Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Acalabrutinib Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Acalabrutinib Market Size by Country (2024-2033) & (US$ Million)
Table 46. AstraZeneca Pharmaceuticals LP Company Detail
Table 47. AstraZeneca Pharmaceuticals LP Business Overview
Table 48. AstraZeneca Pharmaceuticals LP Acalabrutinib Product
Table 49. AstraZeneca Pharmaceuticals LP Revenue in Acalabrutinib Business (2018-2023) & (US$ Million)
Table 50. AstraZeneca Pharmaceuticals LP Recent Development
Table 51. Cephalon, Inc Company Detail
Table 52. Cephalon, Inc Business Overview
Table 53. Cephalon, Inc Acalabrutinib Product
Table 54. Cephalon, Inc Revenue in Acalabrutinib Business (2018-2023) & (US$ Million)
Table 55. Cephalon, Inc Recent Development
Table 56. Genentech, Inc Company Detail
Table 57. Genentech, Inc Business Overview
Table 58. Genentech, Inc Acalabrutinib Product
Table 59. Genentech, Inc Revenue in Acalabrutinib Business (2018-2023) & (US$ Million)
Table 60. Genentech, Inc Recent Development
Table 61. Cayman Chemical Company Company Detail
Table 62. Cayman Chemical Company Business Overview
Table 63. Cayman Chemical Company Acalabrutinib Product
Table 64. Cayman Chemical Company Revenue in Acalabrutinib Business (2018-2023) & (US$ Million)
Table 65. Cayman Chemical Company Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acalabrutinib Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Acalabrutinib Market Share by Type: 2022 VS 2033
Figure 3. Biopharmaceutical Grade Features
Figure 4. Laboratory Grade Features
Figure 5. Global Acalabrutinib Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Acalabrutinib Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Acalabrutinib Report Years Considered
Figure 11. Global Acalabrutinib Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Acalabrutinib Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Acalabrutinib Market Share by Region: 2022 VS 2033
Figure 14. Global Acalabrutinib Market Share by Players in 2022
Figure 15. Global Top Acalabrutinib Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acalabrutinib as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Acalabrutinib Revenue in 2022
Figure 17. North America Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Acalabrutinib Market Share by Country (2018-2033)
Figure 19. United States Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Acalabrutinib Market Share by Country (2018-2033)
Figure 23. Germany Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Acalabrutinib Market Share by Region (2018-2033)
Figure 31. China Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Acalabrutinib Market Share by Country (2018-2033)
Figure 39. Mexico Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Acalabrutinib Market Share by Country (2018-2033)
Figure 43. Turkey Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Acalabrutinib Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. AstraZeneca Pharmaceuticals LP Revenue Growth Rate in Acalabrutinib Business (2018-2023)
Figure 46. Cephalon, Inc Revenue Growth Rate in Acalabrutinib Business (2018-2023)
Figure 47. Genentech, Inc Revenue Growth Rate in Acalabrutinib Business (2018-2023)
Figure 48. Cayman Chemical Company Revenue Growth Rate in Acalabrutinib Business (2018-2023)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries